| Product NDC: | 0078-0478 |
| Proprietary Name: | VOLTAREN |
| Non Proprietary Name: | diclofenac sodium |
| Active Ingredient(s): | 1 mg/mL & nbsp; diclofenac sodium |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0078-0478 |
| Labeler Name: | Novartis Pharmaceutical Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020037 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910328 |
| Package NDC: | 0078-0478-61 |
| Package Description: | 5 mL in 1 BOTTLE, DROPPER (0078-0478-61) |
| NDC Code | 0078-0478-61 |
| Proprietary Name | VOLTAREN |
| Package Description | 5 mL in 1 BOTTLE, DROPPER (0078-0478-61) |
| Product NDC | 0078-0478 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diclofenac sodium |
| Dosage Form Name | SOLUTION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19910328 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceutical Corporation |
| Substance Name | DICLOFENAC SODIUM |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |